Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.42 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.42 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.41 |
| ▸ | IDH1 | O75874 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.40 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | CA6 | P23280 | 1/20 | 0.40 |
| ▸ | CA5A | P35218 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL159711 | 0.90 | ALDH1A1 (0.70) | ALDH1A1MAPTHPGDIDH1LMNA | |
| SCHEMBL14063388 | 0.90 | ALDH1A1 (0.70) | ALDH1A1MAPTHPGDIDH1LMNA | |
| SCHEMBL3082528 | 0.85 | ALDH1A1 (0.60) | ALDH1A1MAPTHPGDIDH1CA12 | |
| SCHEMBL14063396 | 0.84 | ALDH1A1 (0.51) | ALDH1A1MAPTHPGDCTDSP1LMNA | |
| E1501 SCHEMBL11503249 | 0.84 | ALDH1A1 (0.76) | ALDH1A1IDH1CA12AKR1B10AKR1B1 | |
| SCHEMBL14063390 | 0.83 | ALDH1A1 (0.62) | ALDH1A1MAPTHPGDIDH1LMNA | |
| SCHEMBL14063402 | 0.83 | ALDH1A1 (0.53) | ALDH1A1MAPTHPGDCTDSP1LMNA | |
| SCHEMBL9581057 | 0.82 | ALDH1A1 (0.64) | ALDH1A1MAPTHPGDLMNATSHR | |
| SCHEMBL14063398 | 0.82 | ALDH1A1 (0.64) | ALDH1A1MAPTHPGDLMNATSHR | |
| SCHEMBL14063393 | 0.82 | ALDH1A1 (0.64) | ALDH1A1MAPTHPGDLMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1424942-B1 | PORPHYRINS WITH ENHANCED MULTI-PHOTON ABSORPTION CROSS-SECTIONS FOR PHOTODYNAMIC THERAPY | UNIV MONTANA STATE (US) | 2008-12-31 | — | — | EP | disclosed |
| EP-1424942-A4 | PORPHYRINS WITH ENHANCED MULTI-PHOTON ABSORPTION CROSS-SECTIONS FOR PHOTODYNAMIC THERAPY | UNIV MONTANA STATE (US) | 2005-11-23 | — | — | EP | disclosed |
| US-6953570-B2 | Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy | MONTANA STATE UNIVERSITY (US) | 2005-10-11 | — | — | US | disclosed |
| EP-1424942-A1 | PORPHYRINS WITH ENHANCED MULTI-PHOTON ABSORPTION CROSS-SECTIONS FOR PHOTODYNAMIC THERAPY | Montana State University-Bozeman (US) | 2004-06-09 | — | — | EP | disclosed |
| US-20030105070-A1 | Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy | NICKEL JOINT TRUST, THE | 2003-06-05 | — | — | US | disclosed |
| WO-2003017846-A1 | PORPHYRINS WITH ENHANCED MULTI-PHOTON ABSORPTION CROSS-SECTIONS FOR PHOTODYNAMIC THERAPY | MONTANA STATE UNIVERSITY-BOZEMAN (US) | 2003-03-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030105070-A1 | Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy | HMBS, PPOX, PAICS | ALDH1A1 2239/4885MAPT 1431/4885HPGD 1382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.